L?pez de Maturana E, Rodr?guez JA, Alonso L, Lao O, Molina-Montes E, Mart?n-Antoniano IA, G?mez-Rubio P, Lawlor R, Carrato A, Hidalgo M, Iglesias M, Molero X, L?hr M, Michalski C, Perea J, O'Rorke M, Barber? VM, Tard?n A, Farr? A, Mu?oz-Bellv?s L, Crnogorac-Jurcevic T, Dom?nguez-Mu?oz E, Gress T, Greenhalf W, Sharp L, Arnes L, Cecchini L, Balsells J, Costello E, Ilzarbe L, Kleeff J, Kong B, M?rquez M, Mora J, O'Driscoll D, Scarpa A, Ye W, Yu J, Garc?a-Closas M, Kogevinas M, Rothman N, Silverman DT, Albanes D, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Bueno-de-Mesquita B, Buring J, Canzian F, Du M, Gallinger S, Gaziano JM, Goodman PJ, Gunter M, LeMarchand L, Li D, Neale RE, Peters U, Petersen GM, Risch HA, S?nchez MJ, Shu XO, Thornquist MD, Visvanathan K, Zheng W, Chanock SJ, Easton D, Wolpin BM, Stolzenberg-Solomon RZ, Klein AP, Amundadottir LT, Marti-Renom MA, Real FX, Malats N. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 2021 02 01; 13(1):15.